5/2
Public Health
These overlooked global diseases take a turn under the microscope
Faculty at the School of Veterinary Medicine target neglected tropical diseases with advanced science, cross-disciplinary collaborations, and work in the lab and the field.
Without metrics, how do you rate drug treatment facilities?
With no national standard to measure drug treatment facilities, new research reveals opportunities to learn from patients to help create metrics.
Seven years later, PrEP access remains a challenge
Getting PrEP in the hands of high-risk communities remains a challenge; Penn researchers and practitioners are finding ways to reduce barriers and investigate new forms of the drug.
Using science to make cities safer and healthier
In a Q&A, criminologist John MacDonald discusses his new book, grounded in years of research on the positive effects of remediation like fixing up abandoned lots and houses.
How does opioid exposure affect brain development in young children?
That’s the question Allyson Mackey and Dylan Tisdall hope to answer, through a new grant from an NIH initiative focused on addiction research.
A novel approach to treating opioid use disorder
An FDA-approved drug called exendin-4 decreased voluntary oxycodone taking and drug-seeking behavior during withdrawal in rats without reducing the relief the opioid provided.
Algorithm identifies advance care planning needs
A Penn-developed system can be used to ensure that doctors talk to cancer patients about their values and goals before it is too late.
Physicians, social responsibility, and sexual assault survivors
Penn Medicine’s Florencia Greer Polite wants doctors to take a more proactive approach to conversations with their patients about consent and sexual abuse.
As a nursing innovator, Therese Richmond thinks beyond hospital walls
During a four-decade career, Penn Nursing’s associate dean for research and innovation has tackled topics like gun violence by accounting for her patients’ environment in their long-term recovery.
Opioid prescriptions filled after eye surgery doubled over a decade
A Penn study suggests efforts in the past decade to reduce the invasiveness and recovery time for these procedures have not reduced opioid use.
In the News
UPenn hosts free online panel for LGBTQ+ workplace inclusion
The Eidos LGBTQ+ Health Initiative, led by José Bauermeister and Jessica Halem of the School of Nursing, will host a free online panel in April on the integration of LGBTQ+ people in the workforce.
FULL STORY →
Mayor Parker’s plan to ‘remove the presence of drug users’ from Kensington raises new questions
Shoshana Aronowitz of the School of Nursing and Ashish Thakrar of the Perelman School of Medicine comment on the lack of specificity in Philadelphia’s plan to remove drug users from Kensington and on the current state of drug treatment in the city.
FULL STORY →
Posts mislead about COVID-19 vaccine safety with out-of-context clip of FDA official
Jeffrey S. Morris of the Perelman School of Medicine says that many adverse medical events, even those clearly unrelated to vaccines, have been reported an order of magnitude more for COVID vaccines during the pandemic than any time before.
FULL STORY →
Philadelphians hope a cleaner city will reduce gun violence. Will Oh or Parker make it a reality?
A $3 million blight reduction project in Philadelphia is informed by Penn research showing that cleaning up trash and revitalizing vacant lots can reduce gun violence rates by as much as 29%.
FULL STORY →
Universal basic income is working—even in red states
Researchers at Penn concluded that a basic income program in Stockton, California, could have profound positive impacts on local public health.
FULL STORY →
NJ’s Camden County deploying virtual reality to teach students about naloxone
Penn partnered with New Jersey’s Camden County to create a virtual reality training video for administering the opioid-reversing drug Narcan.
FULL STORY →